Takao Hoshino Selected Research

Takao Hoshino Research Topics

Disease

10	Stroke (Strokes) 04/2024 - 01/2017
4	Pathologic Constriction (Stenosis) 07/2022 - 11/2014
3	Ischemic Stroke 11/2022 - 03/2019
2	Acute Coronary Syndrome 01/2023 - 11/2022
2	Atherosclerosis 11/2022 - 07/2022
2	Infarction (Infarctions) 11/2022 - 01/2017
2	Dyslipidemias (Dyslipidemia) 07/2022 - 01/2017
2	Hypertriglyceridemia 07/2022 - 01/2022
2	Infections 03/2022 - 10/2018
1	Insulin Resistance 11/2022
1	Transient Ischemic Attack 11/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2022
1	Cerebral Arterial Diseases 07/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2022
1	Chronic Hepatitis (Chronic Active Hepatitis) 03/2022
1	Embolic Stroke 03/2019
1	Hemiplegia (Spastic Hemiplegia) 02/2019
1	Hepatitis C 10/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Diabetes Mellitus 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Peripheral Arterial Disease 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017
1	Hypothermia 05/2015
1	Ischemia 05/2015
1	Hypoxia (Hypoxemia) 05/2015
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 05/2015
1	Human Influenza (Influenza) 01/2012

Drug/Important Bio-Agent (IBA)

4	omega-Chloroacetophenone (Mace)IBA 01/2023 - 01/2018
3	Triglycerides (Triacylglycerol)IBA 11/2022 - 01/2022
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2017 - 11/2014
1	LipidsIBA 04/2024
1	HomocysteineIBA 09/2023
1	Glucose (Dextrose)FDA LinkGeneric 11/2022
1	salicylhydroxamic acid (SHAM)IBA 11/2022
1	N(G)-iminoethylornithineIBA 11/2022
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 11/2022
1	MK 2206IBA 11/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2022
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 07/2022
1	PPAR alphaIBA 07/2022
1	EnzymesIBA 07/2022
1	glecaprevir and pibrentasvirIBA 03/2022
1	LDL CholesterolIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2019
1	terutrobanIBA 03/2019
1	SteroidsIBA 02/2019
1	Acyclovir (Aciclovir)FDA LinkGeneric 02/2019
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2019
1	paritaprevirIBA 10/2018
1	Ritonavir (Norvir)FDA Link 10/2018
1	ombitasvirIBA 10/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017
1	AnticoagulantsIBA 01/2017
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017
1	Neuroprotective AgentsIBA 05/2015
1	Choline (Choline Chloride)IBA 05/2015
1	Carnitine (L-Carnitine)FDA LinkGeneric 05/2015
1	CarbonIBA 05/2015
1	Pyruvic Acid (Pyruvate)IBA 05/2015
1	Amino Acids FDA Link 05/2015
1	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2015
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 05/2015
1	AntibodiesIBA 01/2012
1	GangliosidesIBA 01/2012

Therapy/Procedure

3	Therapeutics 07/2022 - 02/2019
2	Secondary Prevention 02/2024 - 03/2019
1	Renal Dialysis (Hemodialysis) 09/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2022
1	Stents 06/2022
1	Aftercare (After-Treatment) 03/2022
1	Induced Hypothermia 05/2015